3Deng HX, Zhai H, Bigio EH, et aL FUS- immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol, 2010, 67:739- 748.
4Beleza - Meireles A, Al - Chalabi A. Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives. Amyotroph Lateral Scler, 2009, 10:1-14.
5Beghi E, Chio A, Couratier P, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler, 2011, 12:1-10.
6Byrne S, Walsh C, Lynch C, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta- analysis. J Neurol Neurosurg Psychiatry, 2011, 82:623-627.
7Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry, 2010, 81:385-390.
8Chio A, Mora G, Calvo A, et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology, 2009, 72:725-731.
9O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophie lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry, 2008, 79:30-32.
10Kuzuhara S. Muro disease: amyotrophic lateral sclerosis/ parkinsonism- dementia complex in Kii Peninsula of Japan. Brain Nerve, 2011, 63:119-129.
